Statins to reduce renal sinus fat among breast cancer patients undergoing anthracycline-based chemotherapy: A substudy of PREVENT-WF-98213
Statin administration may lower RSF during anthracycline-based chemotherapy. These findings merit further investigation to determine if statins protect renal function during BC treatment.
Authors
- Moriah P. Bellissimo (ORCID: https://orcid.org/0000-0002-8998-4792)
- Glenn Jay Lesser (ORCID: https://orcid.org/0009-0003-5471-8907)
- Nathaniel S. O’Connell (ORCID: https://orcid.org/0000-0002-3827-5152)
- Kathryn J. Ruddy (ORCID: https://orcid.org/0000-0001-6298-332X)
- Ralph B. D’Agostino (ORCID: https://orcid.org/0000-0002-3550-8395)
- Danielle L. Kirkman (ORCID: https://orcid.org/0000-0003-1648-0662)
- Kerryn W. Reding (ORCID: https://orcid.org/0000-0001-5179-8559)
- Kristine C. Olson (ORCID: https://orcid.org/0000-0002-2952-3003)
- W. Gregory Hundley
- Bonnie Ky (ORCID: https://orcid.org/0000-0002-6628-9981)
- William W. Hundley
Institutions
- Mayo Clinic (US)
- Virginia Commonwealth University (US)
- University of Washington (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- Wake Forest University (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1371/journal.pone.0318017
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00